Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Capstone Therapeutics Corp. (CAPS)

Other OTC - Other OTC Delayed Price. Currency in USD
37.000.00 (0.00%)
At close: 09:10AM EST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
64,295
66,743
45,451
0
2,000
Cost of Revenue
46,971
50,427
34,515
-
254
Gross Profit
17,351
16,316
10,936
-
1,746
Operating Expense
13,363
11,680
8,540
762
1,927
Operating Income
3,988
4,636
2,396
-762
-181
Net Non Operating Interest Income Expense
-1,188
-1,059
-710
-261
-251
Other Income Expense
-
780
-
-
-
Pretax Income
2,800
4,357
1,686
-1,023
-432
Tax Provision
-712
436
-8,486
-24
-52
Net Income Common Stockholders
336
563
8,530
-2,073
-380
Diluted NI Available to Com Stockholders
336
563
8,530
-2,073
-380
Basic EPS
-
7.10
107.60
-38.12
-10.00
Diluted EPS
-
7.10
107.60
-38.12
-10.00
Basic Average Shares
-
79.277
79.277
54.377
54.385
Diluted Average Shares
-
79.277
79.277
54.377
54.385
Total Operating Income as Reported
3,988
4,636
2,396
-762
-181
Total Expenses
60,334
62,107
43,055
762
2,181
Net Income from Continuing & Discontinued Operation
3,512
3,921
10,455
-2,073
-380
Normalized Income
3,512
3,219
9,531
-358
-380
Interest Expense
1,188
1,059
710
-
-
Net Interest Income
-1,188
-1,059
-710
-261
-251
EBIT
3,988
5,416
2,396
-762
-181
EBITDA
4,400
-
-
-
-
Reconciled Cost of Revenue
46,971
50,427
34,515
-
254
Reconciled Depreciation
412
386
245
39
157
Net Income from Continuing Operation Net Minority Interest
3,512
3,921
9,531
-358
-380
Total Unusual Items Excluding Goodwill
0
780
-
-
-
Total Unusual Items
0
780
-
-
-
Normalized EBITDA
4,400
5,022
2,641
-723
-24
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
78.0537
0
0
0
Advertisement
Advertisement